Streetbeat News

Earnings

KRYS

Krystal Biotech anticipates its non-GAAP research and development (R&D) and selling, general, and administrative (SG&A) expenses for fiscal year 2024 to be between $150 million and $175 million.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:03 pm

ICCM

An independent study using IceCure Medical's ProSense treatment reported a 100% tumor reduction in early-stage breast cancer patients deemed inoperable. Conducted in Italy, the study showed complete tumor size reduction at 6 and 12 months post-cryoablation. IceCure Medical Ltd. (NASDAQ:ICCM) shares spiked following the announcement. The ProSense system, which uses cryoablation technology to destroy tumors by freezing, is highlighted for its minimally invasive approach and effectiveness in treating patients who cannot undergo surgery.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:03 pm

LINC

Lincoln Educational Services projects its 2024 revenue to be between $410M and $420M, surpassing the estimated $382.92M.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:02 pm

LINC

Lincoln Educational Services (LINC) reported Q4 2023 GAAP EPS of $0.22, missing the $0.28 estimate, but sales of $102.50M exceeded the $96.20M estimate, marking an 11.68% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:01 pm

ASAN

Recent analysis of Asana (NYSE:ASAN) by 6 financial analysts shows a mixed sentiment, with the latest 12-month price targets suggesting an average target of $21.00, up from the previous $19.00. The ratings range from bullish to somewhat bearish, reflecting diverse perspectives on the company's performance and market position. Asana's financial indicators such as revenue growth, net margin, ROE, and ROA are discussed, highlighting both strengths and areas for improvement.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 1:00 pm

MNDY

Monday.Com (NASDAQ:MNDY) received mixed analyst ratings, with a shift towards bullish sentiment in the last quarter. The average 12-month price target is $229.64, marking a 9.48% increase from the previous target. The company's financial performance shows strong net margin and ROA, but lower ROE and market capitalization compared to industry averages. Analysts' actions and price target adjustments reflect changing market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 1:00 pm

KRYS

Krystal Biotech announced a product revenue, net of $50.7 million for the year ended December 31, 2023, showcasing the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:57 pm

ATNM

Actinium Pharmaceuticals announced that its Iomab-B treatment significantly improves long-term survival rates in older patients with active relapsed/refractory acute myeloid leukemia, according to Phase 3 SIERRA trial results presented at the 2024 Tandem Meetings of ASTCT and CIBMTR.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:38 pm

PEG

Public Service Enterprise (PSEG) has reaffirmed its 2024 adjusted EPS guidance of $3.60 to $3.70, aligning with the consensus of $3.68. Additionally, PSEG announced a $0.12 increase in its annual dividend rate to $2.40 per share, marking 117 consecutive years of dividend payments.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:37 pm

AXON

NVDA

PNST

TOL

WULF

Wall Street's most accurate analysts, with an 87% accuracy rate, have made new stock picks. Brian Bittner of Oppenheimer sees an 87% upside in Pinstripes Holdings Inc. (PNST) after a profitable Q3. William Power of Baird forecasts an 11% rise in Axon Enterprise, Inc. (AXON) ahead of its Q4 earnings. Jay McCanless of Wedbush predicts a 22% downside for Toll Brothers, Inc. (TOL) despite strong Q1 results. Josh Siegler of Cantor Fitzgerald expects a 98% surge in TeraWulf Inc. (WULF) following a debt repayment announcement. Chris Caso of Wolfe Research anticipates over a 14% increase in NVIDIA Corporation (NVDA) after impressive Q4 financials.

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 12:34 pm